Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy
Cancer · 2025-01 · 131 (1)
DOI: 10.1002/cncr.35619 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer, online erschienen am 29.10.2024. Verfasst von Helen M Johnson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Pregnancy Complications, Neoplastic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Jennifer Garlitz Endowment for Research and Treatment of Cancer and Pregnancy.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Prior studies of patients treated for breast cancer during pregnancy (PrBC) report mixed outcomes and are limited by substandard treatment, small cohorts, and short follow‐up. This study compared survival outcomes of PrBC patients treated with chemotherapy during pregnancy with nonpregnant patients matched by age, year of diagnosis, stage, and subtype.
Methods
PrBC patients treated from 1989 to 2022 on prospective institutional protocols were eligible. Disease‐free survival (DFS), overall survival (OS), and progression‐free survival (PFS) were estimated using the Kaplan–Meier method and multivariable Cox proportional hazards regression.
Results
Among 143 PrBC and 285 nonpregnant patients, median follow‐up was 11.4 years. Survival differences were statistically significant, with median DFS and OS not attained for PrBC patients versus 5.6 years (95% confidence interval [CI], 3.6–15.4; p = .0001) and 19.3 years (95% CI, 14.1–not estimated; p = .0262) for nonpregnant patients, respectively. Median PFS was 24.1 years (95% CI, 15.8–not estimated) for PrBC patients versus 8.4 years (95% CI, 6.4–10.9) for the nonpregnant cohort ( p = .0008). Study cohort was associated with DFS, PFS, and OS in multivariable analyses, with the nonpregnant cohort having increased risks of disease recurrence (hazard ratio [HR], 1.91; 95% CI, 1.33–2.76; p = .0005) and disease progression or death (HR, 1.68; 95% CI, 1.19–2.39; p = .0035), and shorter OS (HR, 1.52; 95% CI, 1.01–2.29; p = .0442).
Conclusion
These data suggest that PrBC patients treated with chemotherapy during pregnancy have at least comparable, if not superior, outcomes than nonpregnant patients with similar age, cancer stage, and subtype. Analyses excluding patients with postpartum breast cancer were unable to be performed and are a priority for future confirmatory studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Nursing, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Jennifer K Litton, Oluchi C Oke
Förderung
- NCI NIH HHS
- Jennifer Garlitz Endowment for Research and Treatment of Cancer and Pregnancy
Zitieren
APA
Johnson, H. M., Song, J., Warneke, C. L., Martinez, A. L., Litton, J. K., & Oke, O. C. (2025). Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy. Cancer, 131(1). https://doi.org/10.1002/cncr.35619
Vancouver
Johnson HM, Song J, Warneke CL, Martinez AL, Litton JK, Oke OC. Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy. Cancer. 2025;131(1). doi:10.1002/cncr.35619
BibTeX
@article{Johnson2025,
author = {Johnson, Helen M and Song, Juhee and Warneke, Carla L and Martinez, Ashley L and Litton, Jennifer K and Oke, Oluchi C},
title = {Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy},
journal = {Cancer},
year = {2025},
volume = {131},
number = {1},
doi = {10.1002/cncr.35619}
}
EUVIMED